Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial.

Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial. Circ Heart Fail. 2012 Mar 01; 5(2):217-25.

View in: PubMed

subject areas

Aged
Angiotensin II
Angiotensin II Type 1 Receptor Blockers
Biphenyl Compounds
Female
Follow-Up Studies
Heart Failure
Hospital Mortality
Humans
Male
Minnesota
Stroke Volume
Surveys and Questionnaires
Survival Rate
Systole
Tetrazoles
Time Factors
Treatment Outcome
Ventricular Function, Left

authors with profiles

Michael R. Zile